| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | -0.0066 | 0.8 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | -0.0077 | 0.8 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.0081 | 0.8 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |